Very low density lipoproteins (VLDL) have an abnormal lipid composition in Type 1 (insulin-dependent) diabetic patients. Since VLDL represent a heterogeneous lipoprotein class, this might be due either to a shift in the distribution or to an abnormal composition of VLDL subclasses or both. In order to investigate these possibilities and to evaluate possible pathogenetic mechanisms, lipid composition (non-esterified and esterified cholesterol, triglycerides, phospholipids) of four VLDL subfractions of decreasing size (A: Svedberg flotation unit [Sf] > 400, B: St 175-400, C: St 100-175, D: Sf 20-100), isolated by density gradient preparative ultracentrifugation, and plasma post-heparin lipolytic activity (lipoprotein lipase and hepatic lipase) were evaluated in 13 male normolipidaemic insulin-dependent diabetic patients in good glycaemic control (HbAlo 6.9___0.5%) (mean+SEM) and 9male control subjects matched for age, body mass index and plasma lipid values. Compared to control subjects, diabetic patients showed a reduced total lipid concentration of VLDL of intermediate size (B and C) reaching statistical significance only for VLDL C (0.16 _+ 0.02 vs 0.24 _+ 0.03 mmol/1;p < 0.05). Expressing each VLDL subfraction as percent of the total VLDL lipid concentration, a significant decrease in particles of intermediate size (C) (20.5 + 1.6 vs 27.9 + 1.5 %; p < 0.005) was present, which was compensated by an increase in the smallest ones (D) (50.5 + 2.7 vs 37.4 _+ 3.1%; p < 0.05). VLDL of smaller size were also the only particles with an abnormal composition consisting of a significant increase in esterified cholesterol (12.2+0.8 vs 8.7+1.2%, p <0.01). Post-heparin hepatic lipase activity was significantly reduced in diabetic patients as compared to control subjects (232.9 + 27.9 vs 332 + 42.3 mU/ml; p < 0.05) while post-heparin lipoprotein lipase activity was similar in the two groups. Furthermore, hepatic lipase activity was inversely related to the percentage of smaller VLDL (D) (r = -0.72;p < 0.01) in diabetic patients and this relationship was independent of changes in intermediate VLDL (VLDL C). In conclusion the data suggest that Type i diabetic patients, although normolipidaemic and in good blood glucose control, show a shift in the distribution of VLDL subclasses toward VLDL of a smaller size which also have an abnormal composition. The different distribution of VLDL subfracfions seems to be related to a reduced hepatic lipase activity.
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Growing importance has recently been placed on abnormalities not only in lipid and apoprotein concentrations but also in lipid and apoprotein composition of different lipoproteins in diabetic as well as in non-diabetic individuals [1] [2] [3] .
Many compositional abnormalities of the main lipoproteins (very low density lipoproteins, VLDL; low density lipoproteins, LDL; high density lipoproteins, HDL) have been found in diabetic patients. These alterations may be relevant in explaining, at least in part, the increased predisposition to atherosclerosis in these patients even in the absence of frank hyperlipidaemia [4] [5] [6] [7] .
In particular VLDL composition abnormalities, consisting of an enrichment in cholesterol and a depletion in triglycerides, have been reported in Type i (insulin-dependent) diabetic patients with normal lipid values who are also in optimal blood glucose control [8, 9] . Since VLDL represent a heterogeneous population of particles [10] , the enrichment of total VLDL in cholesterol and their depletion in triglycerides could have three possible explanations: (a) changes occurring in the distribution of different VLDL subclasses; (b) an abnormal composition of one or more VLDL subclaSses; (c) the presence of both of these abnormalities. By evaluating these possibilities the critical steps of the metabolic pathways of VLDL may be characterized. These pathways may be deranged in Type i diabetic patients and very little is known on this subject. Therefore, the first aim of this study was to evalu- Furthermore, the mechanisms by which composition abnormalities of VLDL and other lipoproteins might be explained are, so far, unclear. One of the most plausible causes may be alterations in the activities of lipolytic enzymes. In fact the lipolytic activity represents the key metabolic step in the regulation of the VLDL metabolic cascade [11] and, moreover, the activity of the lipolytic enzymes is mainly regulated by plasma levels of insulin, which are abnormal in Type 1 diabetic patients chronically treated with insulin [12] . Therefore, the second aim of this study was to evaluate whether changes in postheparin plasma lipoprotein and hepatic lipase activity are present in Type i diabetic patients, which might explain the abnormalities in lipoprotein composition observed in these patients.
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Lipoprotein separation
After an overnight fast, blood samples were taken from both diabetic patients and control subjects by venipuncture without stasis. After 30 min at room temperature, to allow blood clotting, serum was recovered by low speed centrifugation (3,000 rev/min) for 10min and added to merthiolate (final concentration 0.01%), EDTA disodium salt and sodium azide (final concentration 0.05 %). For lipoprotein analysis, VLDL were isolated at density (d) 1.006 g/ml by preparative ultracentrifugation [14] ; HDL were precipitated by dextran sulphate magnesium chloride [15] ; LDL were calculated by the difference [16] .
VLDL subfractions were isolated at 1.006 g/ml by discontinuous density gradient ultra centrifugation [17, 18] . This method is based on a four-step density gradient consisting of plasma with a density increased to d 1.10 g/ml with solid NaBr (0.1268 g/ml) and of three different NaBr solutions of decreasing density To form the gradient, 4 ml serum d 1.10 g/ml was transferred to Beckman Ultra-Clear ultracentrifuge tubes (14 x 95 mm) previously coated with a thin layer of polyvinyl alcohol [19] . Three millilitres each of d = 1.065, 1.020 and 1.006 g/ml NaBr solutions were carefully layered above the serum samples. The salt solutions were allowed to gravity feed down the side of wettable centrifuge tubes using a 22 gauge needle. Four VLDL subfractions of decreasing particle size, arbitrarily designated A, B, C, and D, were isolated. Centrifugations were carried out in a Beckman SW 40 Ti rotor at 20 ~ on an Ultracentrifuge CentrikonT2060 (Kontron Instruments, Zurich, Switzerland) with operating mode preselection keys set at "vertical on-off". After correction for acceleration and deceleration forces, four consecutive runs were made: (1) 
Plasma post-heparin lipolytic activities
Subjects and methods
Patients
Thirteen young male Type I diabetic patients diagnosed according to WHO criteria [13] with good blood glucose control and 9 healthy control subjects who were matched with respect to sex, age, BMI, and plasma lipid values participated in the study (Table 1 ). All participants gave their informed consent. The protocol was approved by the ethical committee of the Second Medical School.
All patients were recruited from our diabetic clinic on the basis of normal plasma lipid values (cholesterol<5.7mmol/1; triglyceride < 2.30 mmol/1). None of the patients had abnormal kidney function (glomerular filtration rate < 80 ml/min, albuminuria > 0.5 g/day), retinopathy, hypertension, coronary heart disease or any disease known to influence lipid metabolism. They were on a standard isoenergetic diet, resembling the composition of the habitual diet in southern Italy: 53 % carbohydrate, 17 % protein and 30 % fat most of which was monounsaturated (12-15 %) deriving from olive oil.
All patients were treated by conventional intensified insulin therapy consisting of three injections of regular insulin before meals plus intermediate insulin before dinner. No medication other than insulir/was being taken.
The control subjects were healthy volunteers recruited from the personnel and students of the Institute of Internal Medicine and Metabolic Diseases in Naples.
Blood samples for the measurement of lipoprotein lipase (LPL) and hepatic lipase (HL) activities were collected in EDTA-containing tubes 15 min after intravenous administration of 50 U heparin per kg body weight. Plasma was immediately separated by centrifugation at 4 ~ and stored at -70 ~ LPL and HL activities were determined according to Nilsson-Ehle [20] , using as substrate a (3H) trioleoylglycerol emulsion stabilized by di-oleoyl phosphatidyl choline. Released fatty acids were separated by liquid/liquid partition [21] . Specific measurements of the two lipases are based on differences in pH, NaC1 molarity and presence of serum in the incubation mixture, as well as addition of albumin to the substrate emulsion either before or after sonication. Samples from the diabetic patients were measured in the same assay as their respective matched control subjects. Coefficients of variation were 6.3% and 2.4 % (intra-assay) and 8.9 % and 4.6 % (inter-assay) for LPL and HL, respectively.
Other measurements
Total and non-esterified cholesterol, triglyceride, phospholipids were assayed in serum, isolated lipoproteins and VLDL subfractions by enzymatic colorimetric methods using commercially available kits (Boehringer-Mannheim, Mannheim, FRG) [22] [23] [24] [25] adequately modified in order to get the highest sensitivity for the lowest concentrations. Esterified cholesterol was calculated as the difference between total and non-esterified cholesterol. Quality control of lipid analysis is regularly ensured by the WHO Prague Reference Centre [26] . Recovery of single constituents in VLDL (sum of concentration in VLDL subfractions as percent of concentration in total VLDL) [27] ; normal values in our laboratory are less than 6,7 %.
Statistical analysis
Values in the text are presented as mean + SEM. Statistical evaluation of the differences between diabetic patients and control subjects was performed using the Student's unpaired t-test [28] . Pearson's correlations were performed between lipolytic enzyme activities and VLDL subfractions expressed as a percentage of the total VLDL lipid concentration [28] . The level of statistical significance was set atp < 0.05 for a two-tailed distribution.
Results
The concentration of the major plasma lipoproteins in diabetic patients and control subjects is reported in Table 2 . Although the two groups were well matched for total plasma lipid values, the distribution of triglyceride in plasma lipoproteins was quite different: LDL and HDL of Focusing on VLDL lipid composition, diabetic patients had VLDL particles significantly enriched in ester• cholesterol (8.3 + 0.5 vs 6.0 + 0.9 % of the total lipid concentration, p <0.025), and depleted in triglyceride (61.1 + 0.8 vs 65.4 + 1.6 % ,p < 0.01), which is in agreement with our previous studies [8, 9] .
Lipid concentrations, measured in the four VLDL particles, are reported in Table 3 . The total lipid concentration of intermediate size VLDL (B and C) was reduced in diabetic patients, reaching statistical significance only for VLDL C; in particular in this VLDL subclass the concentrations of non-ester• cholesterol, triglyceride and phospholipids were significantly lower in diabetic patients. The total lipid concentration of VLDL D tended to be somewhat higher with a significant increase in ester• fled cholesterol (p < 0.05) in diabetic patients compared to control subjects.
To quantitate the contribution of each VLDL subclass to total VLDL, the total lipid concentration of each VLDL subfraction was expressed as a percentage of the total VLDL lipid concentration (Fig. 1 ). There is a clear shift in the distribution of VLDL subclasses in diabetic patients compared to control subjects, represented by a significant decrease in intermediate size particles (VLDL C: 20.5 + 1.6 vs 27.9 + 1.5 To ,p < 0.005) and an increase in the smallest particles (VLDL D: 50.5 + 2.7 vs 37.4 + 3.1%, p < 0.005).
The lipid composition of the four different VLDL subclasses (each constituent expressed as percentage of the total lipid concentration) is represented in Figure 2 . No difference was found in the composition of the subfractions of larger and intermediate size (VLDL A, B and C) between diabetic patients and control subjects. Only the The activity of lipolytic enzymes is shown in Figure 3 : post-heparin LPL activity was similar in the two groups (74.5 + 6.3 vs 75.1 + 7.7 mU/ml); onthe other hand HL activity was significantly reduced in diabetic patients as compared to control subjects (232.9+27.9 vs 332.0+ 42.3 mU/ml, p < 0.05).
Correlation analysis between lipolytic enzyme activities and VLDL subfractions, expressed as a percentage of the total VLDL lipid concentration, showed that HL activity was directly related to the percentage of VLDL C (r = 0.61, p < 0.025) and inversely to th e percentage of VLDL D (r = -0.72, p < 0.01) in diabetic patients (Fig. 4) . Since the percentage of VLDL D and C was strictly related, a partial correlation analysis was performed between HL activity, percentage of VLDL C and D. After 
Discussion
The results of this study confirm our and other previous data which demonstrated that, in the absence of hyperlipidaemia (which could confound the analysis of diabetes-induced changes), Type 1 diabetic patients with good blood glucose control are characterized by a shift in the lipoprotein distribution of triglycerides, which are lower in VLDL and higher in LDL and HDL [9, 29] . In the present study the LDL fraction also includes intermediate density lipoproteins (IDL); therefore the LDL enrichment in triglycerides might be due to an increase in IDL fraction. However, in a previous study done by us [9] on a similar group of patients, in which IDL was also separated by ultracentrifugation, LDL remained enriched in triglycerides. Therefore, it is very likely that the enrichment in triglyceride is a real characteristic of the LDL fraction.
The most important finding of this study refers to VLDL subfractions. In fact our data suggest that VLDL abnormalities present in Type 1 diabetic patients may be due to both an abnormal distribution of VLDL subfractions, i. One other study on VLDL subfractions in Type 1 diabetic patients has been published with different results [30] . However, it is very difficult to compare the two studies. In fact, the subfractions isolated by James and Pometta [30] do not match the subfractions we isolated which may have masked the different distribution of VLDL C (separated in the James and Pometta study together with our VLDL A and B) and VLDL D. Moreover, the patients studied are not comparable: our patients were in satisfactory blood glucose control for at least 2 months (as shown by HbAlc values), whereas the patients in James and Pometta's study were in poor glucose control at the beginning of the study and were re-studied only after a very short period of good blood glucose control. The metabolic milieu after a short or long period of good blood glucose control may have different effects on VLDL modifications. Considering the great complexity of lipoprotein metabolism in general, and of VLDL, in particular, it is not easy to identify possible explanations of the mechanisms that could account for our findings. Many hypotheses may be suggested, such as: (1) increased hepatic synthesis or reduced uptake of smaller VLDL (VLDL D) or both; (2) changes in the balance between LPL and HL activities; (3) increased plasma cholesterolester transfer activity. Moreover, a combination of the above mechanisms might play a role.
Changes in lipolytic activity needed to be studied as lipolytic enzymes represent one of the key metabolic steps in VLDL cascade and because the activities of these enzymes are mainly regulated by plasma insulin levels, which can be quite abnormal in chronically treated insulin-dependent diabetic patients. Our Type 1 diabetic patients have normal LPL and a significantly reduced HL activity. This finding may be explained assuming that s. c. insulin therapy normalises peripheral insulin levels in these patients but may not be able to completely restore normal hepatic insulin levels (one of the main regulators of HL activity).
However, a key question is whether the reduction of HL activity found in our diabetic patients can explain the abnormal distribution of VLDL subfractions. HL activity is directed mainly toward the smallest VLDL [31] , which, therefore, should be increased when HL activity is reduced (as in our study). Moreover, the specific role of the reduced HL activity in determining the abnormal distribution of VLDL subfractions in Type i diabetic patients is supported by the highly significant inverse correlation between HL activity and the percentage of the smallest VLDL. This correlation was independent of changes in intermediate size VLDL (VLDL C) as shown by the partial correlation analysis. Of course the decrease in HL may not be the only explanation for the VLDL abnormalities found in Type i diabetic patients. Other mechanisms, i. e. an increased plasma cholesterol transfer activity in diabetic patients as reported by Dullaart et al. [32] , may also be of some importance. This possibility is suggested by other findings of our study, such as the abnormal composition of the smallest VLDL enriched in esterified cholesterol. In fact, this abnormality is not explained by the reduction of HL activity but is in agreement with an increased cholesterol ester transfer protein in 159 Type 1 diabetic patients. It is also important to consider that in well-controlled diabetic patients, as our patients were, there may be a reduction in VLDL synthesis [33] , which could explain the decrease of the lipid concentration in VLDL subfractions of intermediate size.
Our data on LPL show that the activity of this enzyme is similar in Type 1 diabetic patients and control subjects. Therefore, LPL activity does not seem to be contributing to the VLDL abnormalities found in our patients. This last result is quite controversial as it is generally believed that LPL activity is increased in Type I diabetic patients on subcutaneous insulin therapy as a consequence of peripheral hyperinsulinization [1, 34] . However, it is important to remember that our patients, different from those of other studies, are well matched to control subjects in terms of plasma lipid values, sex, age and BMI. Moreover, they have had long-term treatment with human insulin according to an intensifed regimen. Thus, the peripheral free insulin levels (not measured in our study) are not likely to be very high with this type of treatment.
In conclusion, Type i diabetic patients, although normolipidaemic and in satisfactory blood glucose control, still show lipoprotein abnormalities, in particular, VLDL. These abnormalities may, at least in part, be explained by a reduced HL activity. Furthermore, it should be emphasized that VLDL abnormalities observed in Type 1, as well as in Type 2 (non-insulin-dependent) diabetic patients [35] , seem mostly to be due to a relative increase (and an enrichment in esterified cholesterol) of the smallest VLDL subfractions (VLDL D), which are the VLDL particles more actively involved in the atherogenic process [36] . This leads to the hypothesis that lipoprotein composition abnormalities found in diabetic patients could play a role in the increased predisposition to cardiovascular disease observed in these patients.
